UNIGE document Scientific Article
previous document  unige:19796  next document
add to browser collection

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice

Emamaullee, Juliet A.
Davis, Joy
Merani, Shaheed
Elliott, John F.
Thiesen, Aducio
Shapiro, A M James
Published in Diabetes. 2009, vol. 58, no. 6, p. 1302-1311
Abstract OBJECTIVE: The T helper 17 (Th17) population, a subset of CD4-positive T-cells that secrete interleukin (IL)-17, has been implicated in autoimmune diseases, including multiple sclerosis and lupus. Therapeutic agents that target the Th17 effector molecule IL-17 or directly inhibit the Th17 population (IL-25) have shown promise in animal models of autoimmunity. The role of Th17 cells in type 1 diabetes has been less clear. The effect of neutralizing anti-IL-17 and recombinant IL-25 on the development of diabetes in NOD mice, a model of spontaneous autoimmune diabetes, was investigated in this study. RESEARCH DESIGN AND METHODS AND RESULTS: Although treatment with either anti-IL-17 or IL-25 had no effect on diabetes development in young (<5 weeks) NOD mice, either intervention prevented diabetes when treatment was started at 10 weeks of age (P < 0.001). Insulitis scoring and immunofluorescence staining revealed that both anti-IL-17 and IL-25 significantly reduced peri-islet T-cell infiltrates. Both treatments also decreased GAD65 autoantibody levels. Analysis of pancreatic lymph nodes revealed that both treatments increased the frequency of regulatory T-cells. Further investigation demonstrated that IL-25 therapy was superior to anti-IL-17 during mature diabetes because it promoted a period of remission from new-onset diabetes in 90% of treated animals. Similarly, IL-25 delayed recurrent autoimmunity after syngeneic islet transplantation, whereas anti-IL-17 was of no benefit. GAD65-specific ELISpot and CD4-positive adoptive transfer studies showed that IL-25 treatment resulted in a T-cell-mediated dominant protective effect against autoimmunity. CONCLUSIONS: These studies suggest that Th17 cells are involved in the pathogenesis of autoimmune diabetes. Further development of Th17-targeted therapeutic agents may be of benefit in this disease.
Keywords Adoptive TransferAnimalsAntibodies, MonoclonalAutoantibodies/analysisDiabetes Mellitus, Type 1/*immunologyDisease ProgressionEnzyme-Linked Immunosorbent AssayFlow CytometryGlutamate Decarboxylase/genetics/immunologyHomeodomain Proteins/geneticsIslets of Langerhans TransplantationMiceMice, Inbred NODMice, KnockoutRecombinant Proteins/immunologyT-Lymphocytes, Helper-Inducer/*immunology/*transplantation
PMID: 19289457
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Research group Transplantation et hépatologie (905)
(ISO format)
EMAMAULLEE, Juliet A. et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. In: Diabetes, 2009, vol. 58, n° 6, p. 1302-1311. doi: 10.2337/db08-1113 https://archive-ouverte.unige.ch/unige:19796

417 hits

0 download


Deposited on : 2012-04-23

Export document
Format :
Citation style :